K E Hellström

8.9k total citations · 1 hit paper
106 papers, 7.1k citations indexed

About

K E Hellström is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, K E Hellström has authored 106 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Radiology, Nuclear Medicine and Imaging, 57 papers in Immunology and 49 papers in Molecular Biology. Recurrent topics in K E Hellström's work include Monoclonal and Polyclonal Antibodies Research (56 papers), Immunotherapy and Immune Responses (39 papers) and Glycosylation and Glycoproteins Research (23 papers). K E Hellström is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (56 papers), Immunotherapy and Immune Responses (39 papers) and Glycosylation and Glycoproteins Research (23 papers). K E Hellström collaborates with scholars based in United States, Germany and South Africa. K E Hellström's co-authors include Ingegerd Hellström, Joseph P. Brown, I Hellström, Hans Sjögren, S. C. Bansal, M Y Yeh, Lieping Chen, J E Casnellie, H. Jacques Garrigues and Ursula Garrigues and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

K E Hellström

106 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Suggestive Evidence That the “Blocking Antibodies” of Tumor-Bearing Individuals May Be Antigen-Antibody Complexes

1971 560 citations Hans Sjögren, Ingegerd Hellström et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K E Hellström United States	47	3.1k	3.1k	3.0k	2.0k	532	106	7.1k
Dorothee Herlyn United States	46	3.2k 1.0×	3.8k 1.2×	3.9k 1.3×	3.3k 1.6×	432 0.8×	154	8.4k
Gerhard Moldenhauer Germany	52	2.9k 0.9×	1.8k 0.6×	3.4k 1.1×	2.7k 1.3×	376 0.7×	129	7.6k
H. Michael Shepard United States	39	2.0k 0.6×	3.8k 1.2×	4.5k 1.5×	4.8k 2.4×	1.2k 2.3×	64	9.3k
Gert Riethmüller Germany	47	3.3k 1.1×	1.9k 0.6×	3.1k 1.0×	5.1k 2.5×	609 1.1×	112	10.4k
Silvana Canevari Italy	49	2.2k 0.7×	1.9k 0.6×	4.4k 1.4×	3.2k 1.6×	770 1.4×	227	8.7k
Zenon Steplewski United States	51	3.4k 1.1×	5.3k 1.7×	6.2k 2.0×	3.1k 1.5×	643 1.2×	172	11.0k
David W. Scott United States	49	4.2k 1.3×	1.4k 0.5×	2.8k 0.9×	1.5k 0.8×	925 1.7×	287	8.0k
Stephen D. Gillies United States	50	4.5k 1.4×	2.4k 0.8×	4.0k 1.3×	3.7k 1.8×	1.4k 2.6×	153	9.8k
Maria I. Colnaghi Italy	40	1.5k 0.5×	1.8k 0.6×	2.1k 0.7×	1.8k 0.9×	354 0.7×	171	4.8k
Kenneth O. Lloyd United States	61	4.1k 1.3×	3.8k 1.3×	8.0k 2.7×	1.7k 0.8×	416 0.8×	186	11.7k

Countries citing papers authored by K E Hellström

Since Specialization

Citations

This map shows the geographic impact of K E Hellström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K E Hellström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K E Hellström more than expected).

Fields of papers citing papers by K E Hellström

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K E Hellström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K E Hellström. The network helps show where K E Hellström may publish in the future.

Co-authorship network of co-authors of K E Hellström

This figure shows the co-authorship network connecting the top 25 collaborators of K E Hellström. A scholar is included among the top collaborators of K E Hellström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K E Hellström. K E Hellström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tuve, Sebastian, Ying Liu, Khajornsak Tragoolpua, et al.. (2009). In situ adenovirus vaccination engages T effector cells against cancer. Vaccine. 27(31). 4225–4239. 37 indexed citations

McIntosh, Martin, Charles W. Drescher, Beth Y. Karlan, et al.. (2004). Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma. Gynecologic Oncology. 95(1). 9–15. 158 indexed citations

Disis, Mary L., Nathalie Scholler, Amber Dahlin, et al.. (2003). Plasmid-based vaccines encoding rat neu and immune stimulatory molecules can elicit rat neu-specific immunity.. PubMed. 2(10). 995–1002. 14 indexed citations

Blake, James, Janet Johnston, K E Hellström, Hans Marquardt, & Lieping Chen. (1996). Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytes.. The Journal of Experimental Medicine. 184(1). 121–130. 48 indexed citations

Johnston, Janet, Alison R. Malacko, Patrick O. McGowan, et al.. (1996). B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes.. The Journal of Experimental Medicine. 183(3). 791–800. 82 indexed citations

Yelton, D E, Mae Joanne Rosok, W L Cosand, et al.. (1995). Affinity maturation of the BR96 anti-carcinoma antibody by codon-based mutagenesis. The Journal of Immunology. 155(4). 1994–2004. 53 indexed citations

Maresh, Grace A., et al.. (1994). Differential Processing and Secretion of the Melanoma-Associated Me20 Antigen. Archives of Biochemistry and Biophysics. 311(1). 95–102. 34 indexed citations

Li, Yongsheng, Patrick O. McGowan, Ingegerd Hellström, K E Hellström, & Lieping Chen. (1994). Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma.. The Journal of Immunology. 153(1). 421–428. 124 indexed citations

Casazza, Anna Maria, Pamela A. Trail, & K E Hellström. (1994). Drug immunotargeting for carcinomas: A reality at last?. Annals of Oncology. 5(8). 703–708. 6 indexed citations

10.

Siegall, Clay B., Dana F. Chace, Bruce Mixan, et al.. (1994). In vitro and in vivo characterization of BR96 sFv-PE40. A single-chain immunotoxin fusion protein that cures human breast carcinoma xenografts in athymic mice and rats.. The Journal of Immunology. 152(5). 2377–2384. 36 indexed citations

11.

Trail, Pamela A., David Willner, Shirley J. Lasch, et al.. (1993). Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates. Science. 261(5118). 212–215. 414 indexed citations

12.

Ziegler, L. D., J Cunningham, K Itoh, et al.. (1992). Phase I trial of murine monoclonal antibody L6 in combination with subcutaneous interleukin-2 in patients with advanced carcinoma of the breast, colorectum, and lung.. Journal of Clinical Oncology. 10(9). 1470–1478. 31 indexed citations

13.

Huse, William D., Scott Glaser, Lisa Starr, et al.. (1992). Application of a filamentous phage pVIII fusion protein system suitable for efficient production, screening, and mutagenesis of F(ab) antibody fragments. The Journal of Immunology. 149(12). 3914–3920. 36 indexed citations

14.

Hirschberg, David L., George J. Schreiber, K Thor, et al.. (1991). Monoclonal antibody L6-daunomycin conjugates constructed to release free drug at the lower pH of tumor tissue. Cancer Immunology Immunotherapy. 33(4). 223–230. 26 indexed citations

15.

Hellström, Ingegerd, et al.. (1989). Cyclophosphamide potentiates the antitumor activity of v-p97NY. Cellular Immunology. 120(1). 126–131. 9 indexed citations

16.

Larson, Steven M., Andrew Raubitschek, James C. Reynolds, et al.. (1989). Comparison of bone marrow dosimetry and toxic effect of high dose 131I-labeled monoclonal antibodies administered to man. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 16(2). 153–158. 20 indexed citations

17.

Lark, Michael W., Tet-Kin Yeo, H Mar, et al.. (1988). Arterial chondroitin sulfate proteoglycan: localization with a monoclonal antibody.. Journal of Histochemistry & Cytochemistry. 36(10). 1211–1221. 43 indexed citations

18.

Nepom, Gerald T., et al.. (1984). Induction of immunity to a human tumor marker by in vivo administration of anti-idiotypic antibodies in mice.. Proceedings of the National Academy of Sciences. 81(9). 2864–2867. 47 indexed citations

19.

Nepom, Gerald T., Ingegerd Hellström, & K E Hellström. (1983). Suppressor mechanisms in tumor immunity. Cellular and Molecular Life Sciences. 39(3). 235–242. 25 indexed citations

20.

Bansal, S. C., K E Hellström, I Hellström, & Hans Sjögren. (1973). CELL-MEDIATED IMMUNITY AND BLOCKING SERUM ACTIVITY TO TOLERATED ALLOGRAFTS IN RATS. The Journal of Experimental Medicine. 137(3). 590–602. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact